2025-2026 Global Cancer Program Fellows
Mwajuma Jumbe, MD, MMED is a Women's Imaging Super-specialist at Muhimbili National Hospital and serves as an honorary lecturer at Muhimbili University of Health and Allied Sciences (MUHAS). She obtained her undergraduate degree from MUHAS, completed postgraduate training in Radiology at Central South University in China, and pursued advanced specialization in women's imaging at MUHAS through a program supported by (RSNA) under its Global Learning Center initiative. She is engaged in breast cancer advocacy and leads capacity-building efforts aimed at enhancing awareness, clinical knowledge, and procedural skills particularly in core needle biopsies; with the objective of improving diagnostic accuracy and expanding access to minimally invasive care across Tanzania. In late 2023, she completed an international observership in breast imaging at the University of Virginia. She is an active member of RSNA and SBI. Her research focuses on the early detection of breast cancer, emphasizing standardized reporting systems like BI-RADS and supporting healthcare providers in making informed decisions in breast imaging.
Phocas Havugimana, MD is a Rwandan internal medicine specialist and medical oncology fellow affiliated with King Faisal Hospital and the University of Rwanda. With nearly a decade of clinical experience, he is actively engaged in oncology care, education, and research in a resource-constrained setting. Dr. Havugimana's work focuses on developing standardized protocols, enhancing multidisciplinary cancer care, and integrating research into clinical practice. Motivated by a strong desire to improve cancer outcomes in Rwanda, he seeks exposure to global best practices in oncology to inform and strengthen national programs. His participation in UCSF’s “Designing Clinical Research” course, the GCP Fellowship, and his interest in thoracic malignancies reflect his dedication to advancing oncology training and care delivery in Rwanda.
Nguyen Thi Lan, MD is a clinical oncologist at Vietnam National Cancer Hospital, Vietnam. She graduated from the general medicine program at Hanoi Medical University. She then pursued a master's degree and completed residency training in oncology at Hanoi Medical University, with clinical practice mainly at K Hospital. Currently, she works as a pediatric oncologist at the Pediatrics Department, K Hospital. She is particularly interested in improving treatment outcomes and quality of life for pediatric patients with hematologic cancers, sarcomas, brain tumors, retinoblastoma, and other malignant diseases.
Godfrey Malangwa MD, MMED, MPH, PhD candidate, is an experienced Public Health Specialist, Clinical Oncologist and Radiation Oncologist with extensive expertise in providing high-quality healthcare services. He is dedicated to advancing patient outcomes through specialized treatment plans and comprehensive care. His professional journey includes notable contributions to oncology research, palliative counselling, project management, monitoring, and evaluation. He holds multiple advanced degrees in clinical oncology and public health and project management, monitoring and evaluation, and he is a PhD Candidate in Molecular Biology and Biotechnology at the University of Dar es Salaam.
Deogratius Beda Mwanakulya, MD/MMed is a Clinical Oncologist in Tanzania and currently serves as the head of Adult Oncology Unity at Muhimbili National Hospital. He is an active member of Tanzania Oncology Society (TOS), American Society of Clinical Oncology (ASCO), African Organisation for Research and Training in Cancer (AORTIC), European Society for Medical Oncology (ESMO), and a co-founder of the Tanzania Liver Cancer Group. He attained his MBBS from Tianjin Medical University and completed a Master of Medicine at Xian Jiaotong University. The research during his master’s degree, which was laboratory-based, focused on pathways of COX-2 inhibition by Celecoxib in different types of breast cancer cells.
Practicing in Tanzania, he has seen firsthand how liver cancer, particularly hepatocellular carcinoma (HCC), continues to cause high morbidity and mortality in our population. Limited early detection, lack of access to effective treatment, and a paucity of context-specific research contribute to poor outcomes. He beleives that rigorous scientific investigation can transform these realities, and is eager to contribute meaningfully through advanced research training in Hepatocellular Carcinoma.
Tran Hai Nam, MD is a pediatric oncologist at Vietnam National Cancer Hospital (K Hospital) in Hanoi, Viet Nam. He cares for children with blood cancers and solid tumors and leads practical, outcomes-focused research. His primary project centers on treatment results in rhabdomyosarcoma (RMS) from 2021-2025; he is finalizing a study on high-risk RMS and building pragmatic care pathways that fit Vietnam’s context. He also works on eye-sparing management for retinoblastoma and survivorship follow-up. Dr. Nam collaborates with the UCSF Global Cancer Program and Vietnamese partners to strengthen diagnosis, supportive care, and training nationwide. Beyond the clinic, he organizes community efforts to protect and support children with cancer and their families.
Nguyen Thi Thu Nhung, MD is a radiation oncologist at Viet Nam National Cancer Hospital (K Hospital), where she has worked for eight years and specialized for five years in pediatric radio-oncology, CNS tumors, and head and neck cancer treatment. She has hands-on experience with advanced techniques such as VMAT, IMRT, and pediatric anesthesia for radiation therapy and is preparing to implement SBRT and IMPT in the near future. Dr. Nhung has published multiple peer-reviewed papers on nasopharyngeal carcinoma, thyroid cancer, glioblastoma, and pediatric CNS germ cell tumors. Her current research focuses on optimizing and improving multimodality treatment strategies for CNS, pediatric cancer such as sarcoma, lymphoma and head & neck cancers. She is passionate about enhancing the quality of patient care and advancing pediatric radiation oncology practice in Vietnam through international collaboration and evidence-based treatment.
Lilian Evaristo Salingwa, MD, MMED is a Clinical Radiologist and Lecturer at the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, Tanzania. Her journey into cardio-oncology began at her working station, where she witnessed challenges faced by breast cancer patients receiving chemotherapy and the silent but devastating impact of cardiotoxicity. Trained in Radiology, she combines her clinical expertise with a passion for research and mentorship. Dr. Salingwa has contributed to studies on cardiovascular complications in people living with HIV, carotid atherosclerosis in diabetes (supports by THET and SIDA respectively), and imaging in chronic lung disease, sharing her findings at national scientific conferences. She is committed to bridging the gap between cancer care and cardiovascular health in low-resource settings. Through the UCSF Global Cancer Fellowship, she hopes to grow as a clinician-scientist, advance evidence-based cardio-oncology practices, and mentor the next generation of researchers in Tanzania and beyond.
Emmanuel Saukiwa, MSc is an Assistant Lecturer in Biochemistry and Molecular Biology at Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania. A molecular scientist with extensive expertise in next-generation sequencing, he has led pioneering efforts to introduce liquid biopsy technologies into cancer research and care in sub-Saharan Africa. As laboratory lead for the AIREAL study, the first global health project to implement cfDNA-based diagnostics for Burkitt lymphoma in the region, he helped build local capacity for precision oncology and contributed to high-impact publications in Nature and Blood. Emmanuel holds an MSc in Precision Cancer Medicine from the University of Oxford and is a recipient of the International Myeloma Society Young Investigator Award. His research focuses on harnessing genomic and liquid biopsy approaches to advance cancer diagnosis, treatment monitoring, and equitable access to precision medicine in low-resource settings.
Eunice Andrew Shija, MD, MMED is a hematologist from Tanzania, currently serving as a Medical Specialist at Muhimbili National Hospital, where she is the bone marrow transplant coordinator and head of the hematology unit. She is also an honorary lecturer at Muhimbili University of Health and Allied Sciences. Dr. Shija is a member of the European Hematology Association (EHA) and the EHA-specialized working group for myelodysplastic syndromes (EHA-MDS-SWG).Her work focuses on hematopathology and myeloid malignancies, particularly (MDS). She is committed to addressing diagnostic and research gaps in MDS within Tanzania by integrating molecular diagnostics, establishing a local patient registry, and advancing precision medicine for myeloid malignancies. Motivated by a commitment to improve cancer care in resource-limited settings, she is leveraging global training experiences, including awards from the American Society of Hematology and American society of clinical oncology-AORTIC, to generate locally relevant, impactful data to improve patient outcomes.
Nguyen Thi Thao, MD is a Haematologist at the National Institute of Hematology and Blood Transfusion, Hanoi, Vietnam (NIHBT). After completing her residency, she received her medical degree from the Hanoi Medical University. Her clinical focus on Multiple Myeloma, Lymphomas, Myelodysplastic Syndrome and Myeloproliferative Neoplasms. Her research interests lie in improving diagnosis and treatment of cancer patients, particularly those with Lymphoma and Multiple Myeloma, in order to enhance the quality of life for individuals with these and other haematologic malignancies.
Douglass Morris II is an MD/MS candidate in the UC Berkeley–UCSF Joint Medical Program. He earned a BA in Neurobiology from the College of Wooster and previously served as a Cancer Research Training Fellow in the Pediatric Oncology Branch at the National Cancer Institute, where he applied computational approaches to study therapeutic targets across pediatric solid tumors, with a primary focus on metastatic osteosarcoma. Currently, he is contributing to the development of a disease-focused tumor board and preparing to lead a cascade analysis of the childhood cancer care continuum at Muhimbili National Hospital in Dar es Salaam, Tanzania. His project seeks to identify points of delay and loss to follow-up in order to strengthen care delivery and resource allocation. Douglass is committed to advancing cancer care in Eastern sub-Saharan Africa and looks forward to growing as a future physician-scientist through the UCSF Global Cancer Fellowship.